PUBLISHED FRI, APR 23 20214:51
A CDC advisory panel on Friday recommended the U.S. resume using the Johnson and Johnson Covid-19 vaccine.
Members of the panel also proposed that the FDA include a warning label for women under age 50.
The recommendation will pave the way for U.S. regulators to lift their recommended pause on using the J&J shot as early as this weekend.
J&J executives told the committee the benefits of its vaccine still outweighed its risks, adding that the shots would prevent deaths and hospitalizations. They suggested a new warning label for the vaccine that explains the risk of blood clots.
More at source
